Form S-1 Vaxart, Inc.
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260508/A8Z2BQ2CZC22KZZN222I2ZZZG8MSG6W8Z282
Filed on: May 8, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Creatd files Form S-1 and reports Q1 2026 financial results
- Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting
- Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
